The companies have developed a Level 4 traceability solution to manage pharmaceutical regulatory requirements.
Microsoft and Adents have combined efforts to jointly develop and commercialize a new cloud platform called Adents Prodigi. The platform is a Level 4 traceability solution that can centrally manage regulatory requirements imposed on the pharmaceutical industry as well as allow laboratories and CMOs to use data generated during the serialization and track and trace processes.
Adents Prodigi was released in Oct. 2016 and relies on advanced Microsoft Azure technologies. The platform allows drug manufacturers to securely generate, exchange, and control the data created through unit identification. The Adents Prodigi platform also integrates data analysis (including Microsoft Power BI) and machine learning tools, providing analytical capabilities for these new sources of information.
Adents Prodigi was developed collaboratively by a cross-disciplinary team of Adents and Microsoft experts, and can host business applications offered by third parties to fully exploit data stored on the platform. In total, Adents Prodigi stands as a solution to ensure compliance with new regulations while efficiently mining and utilizing new data to manage production and distribution practices.
Source: Microsoft Adents
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.